<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(1)</volume><submitter>Itaba N</submitter><pubmed_abstract>Chronic hepatitis viral infection, alcoholic intoxication, and obesity cause liver fibrosis, which progresses to decompensated liver cirrhosis, a disease for which medical demands cannot be met. Since there are currently no approved anti-fibrotic therapies for established liver fibrosis, the development of novel modalities is required to improve patient prognosis. In this study, we clarified the anti-fibrotic effects of cell sheets produced from human bone marrow-derived mesenchymal stem cells (MSCs) incubated on a temperature-sensitive culture dish with the chemical compound IC-2. Orthotopic transplantation of IC-2-engineered MSC sheets (IC-2 sheets) remarkably reduced liver fibrosis induced by chronic CCl&lt;sub>4&lt;/sub> administration. Further, the marked production of fibrolytic enzymes su</pubmed_abstract><journal>Scientific reports</journal><pagination>6841</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6497888</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets.</pubmed_title><pmcid>PMC6497888</pmcid><pubmed_authors>Kono Y</pubmed_authors><pubmed_authors>Oka H</pubmed_authors><pubmed_authors>Yokobata T</pubmed_authors><pubmed_authors>Kakuta H</pubmed_authors><pubmed_authors>Shiota G</pubmed_authors><pubmed_authors>Morimoto M</pubmed_authors><pubmed_authors>Watanabe K</pubmed_authors><pubmed_authors>Osaki M</pubmed_authors><pubmed_authors>Itaba N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Reversal of established liver fibrosis by IC-2-engineered mesenchymal stem cell sheets.</name><description>Chronic hepatitis viral infection, alcoholic intoxication, and obesity cause liver fibrosis, which progresses to decompensated liver cirrhosis, a disease for which medical demands cannot be met. Since there are currently no approved anti-fibrotic therapies for established liver fibrosis, the development of novel modalities is required to improve patient prognosis. In this study, we clarified the anti-fibrotic effects of cell sheets produced from human bone marrow-derived mesenchymal stem cells (MSCs) incubated on a temperature-sensitive culture dish with the chemical compound IC-2. Orthotopic transplantation of IC-2-engineered MSC sheets (IC-2 sheets) remarkably reduced liver fibrosis induced by chronic CCl&lt;sub>4&lt;/sub> administration. Further, the marked production of fibrolytic enzymes su</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2025-04-18T15:28:05.976Z</modification><creation>2019-06-06T23:26:45Z</creation></dates><accession>S-EPMC6497888</accession><cross_references><pubmed>31048740</pubmed><doi>10.1038/s41598-019-43298-0</doi></cross_references></HashMap>